癌症治疗中的铁:机制,小分子诱导剂和新的方法
YiLin Luo1, Xin Yue Bai1, Lei Zhang1
1Yan 'an Small Molecule Innovative Drug R&D Engineering Research Center, School of Medicine, Yan'an University, Yan'an, People's Republic of China.
Drug design, development and therapy
|June 26, 2024
概括
铁亡,一种被编程的细胞死亡,是一个有前途的癌症治疗策略. 本综述探讨了用于向瘤治疗的铁灭诱导剂,包括小分子,PROTACs和纳米药物.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 在瘤学瘤学.
背景情况:
- 铁亡是一种独特的被编程细胞死亡形式,由铁的积累和脂质过氧化驱动.
- 瘤的进展与铁亡密切相关,癌细胞由于新陈代谢和铁水平的增加而表现出更高的脆弱性.
- 针对性诱导铁灭症为癌症治疗提供了一个有前途的治疗途径.
研究的目的:
- 审查铁灭的调节机制.
- 为了检查传统的小分子铁灭诱导剂在各种瘤中的作用.
- 总结使用新方法诱导铁亡的近期进展.
主要方法:
- 关于铁亡调节机制的文献综述.
- 分析传统的小分子铁灭症诱导剂的疗效.
- 在PROTACs,PDT,SDT和基于纳米材料的ferroptosis诱导方面取得的最新进展的汇编.
主要成果:
- 铁化是瘤进展中的关键调节剂.
- 小分子诱导剂在各种瘤类型中表现出有效性.
- 像PROTAC,PDT,SDT和纳米材料这样的新兴策略为ferroptosis诱导提供了新的途径.
结论:
- 有针对性的铁灭症诱导是一种可行的癌症治疗策略.
- 需要进一步的研究来发现新的标,并提高诱导剂的选择性.
- 减少有毒副作用对于诱导铁亡的药物的临床转化至关重要.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


